Colm Keane

15PUBLICATIONS
125CO-AUTHORS
Haematological tumoursComputational imagingPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 02, 2026
Phase 1/2 study of favezelimab plus pembrolizumab in anti-PD-1-naive relapsed or refractory classical Hodgkin lymphoma.

|Mar 24, 2026
Same-Slide Spatial Multiomics Integration with IN-DEPTH Reveals Tumor Virus-Linked Spatial Reorganization of the Tumor Microenvironment.

Stephanie Pei Tung Yiu, Yuzhou Chang, Yao Yu Yeo

|Jun 27, 2025
Refinement of primary central nervous system lymphoma prognostication and response assessment using 3-dimensional MRI.

Jack O'Shaughnessy, Arina Martynchyk, Sze Ting Lee

|Jun 20, 2025
T-cell dysregulation informs radiotherapy-immunotherapy response in B-cell lymphoma: results from a phase 1 trial.

Eliza A Hawkes, Jodie B Palmer, Richard Khor

|Jan 24, 2025
Nivolumab and rituximab in treatment-naïve follicular lymphoma: the phase 2 1st FLOR study.

Allison Barraclough, Sze Ting Lee, Melinda Burgess

|Oct 22, 2024
Genetic and immunological features of immune deficiency and dysregulation-associated lymphoproliferations and lymphomas as a basis for classification.

Daan Dierickx, Colm Keane, Yasodha Natkunam

Pageof 3

Frequent Collaborators

6 joint publications

Maher K Gandhi

5 joint publications

Eliza A Hawkes

4 joint publications

Jay Gunawardana

4 joint publications

Soi-Cheng Law